Making sense of the latest advice on vitamin D therapy

Journal of the American Society of Nephrology

Volumn 22, Issue 6, 2011, Pages 994-998

  Monk, Rebeca D ^a   Bushinsky, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

CALCIUM INTAKE; CANCER RISK; CHRONIC KIDNEY DISEASE; HORMONE RELEASE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; MALE; NOTE; PANCREAS CANCER; PRIORITY JOURNAL; RISK REDUCTION; VITAMIN D INTOXICATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 79957785367     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011030251     Document Type: Note

References (53)

1. Institute of Medicine (IOM): Dietary Reference Intakes for Calcium and Vitamin D, Washington DC, National Academies Press, 2011
2. Holick MF: Vitamin D Deficiency. N Engl J Med 357: 266-281, 2007
3. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R: Estimates of optimal vitamin D status. Osteoporos Int 16: 713-716, 2005 (Pubitemid 40933586)
4. DeLuca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: 1689S-1696S, 2004
5. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678S-1688S, 2004
6. Jones G: Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88: 582S-586S, 2008
7. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J: Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91: 2552-2555, 1993 (Pubitemid 23182508)
8. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 116: 2062-2072, 2006
9. Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, Wernroth L, Michaelsson K: Determining vitamin D status: A comparison between commercially available assays. PLoS One 5: e11555, 2010
10. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C: Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 45: 153-159, 2008 (Pubitemid 351724586)
11. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK: HPLC method for 25-hydroxyvitamin D measurement: Comparison with contemporary assays. Clin Chem 52: 1120-1126, 2006 (Pubitemid 43794425)
12. de la HA, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M: UK Food Standards Agency Workshop Consensus Report: The choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 104: 612-619, 2010
13. Cantor TL: Lack of evidence for administering vitamin D analogs to kidney failure patients to improve survivability. Clin Nephrol 72: 97-104, 2009
14. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V: Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (158): 1-235, 2007
15. Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 351: 805-806, 1998 (Pubitemid 28112350)
16. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7: 439-443, 1997 (Pubitemid 27443069)
17. Fraser WD, Ahmad AM, Vora JP: The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis. Curr Opin Nephrol Hypertens 13: 437-444, 2004 (Pubitemid 38901623)
18. Vieth R, Ladak Y, Walfish PG: Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88: 185-191, 2003 (Pubitemid 36115163)
19. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM: Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10: 1177-1184, 1995
20. Patel S, Hyer S, Barron J: Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone. Calcif Tissue Int 80: 221-226, 2007 (Pubitemid 46675247)
21. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G: Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294: 2336-2341, 2005 (Pubitemid 41607410)
22. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF: Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82: 4111-4116, 1997 (Pubitemid 27525523)
23. Heaney RP: Optimal vitamin D status. J Bone Miner Res 24: 755, 2009
24. Heaney RP: The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97: 13-19, 2005
25. Heaney RP, Dowell MS, Hale CA, Bendich A: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22: 142-146, 2003 (Pubitemid 36417827)
26. Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM: Vitamin D insufficiency: Disease or no disease? J Bone Miner Res 23: 1052-1060, 2008
27. Aloia JF, Chen DG, Yeh JK, Chen H: Serum vitamin D metabolites and intestinal calcium absorption efficiency in women. Am J Clin Nutr 92: 835-840, 2010
28. Kinyamu HK, Gallagher JC, Rafferty KA, Balhorn KE: Dietary calcium and vitamin D intake in elderly women: Effect on serum parathyroid hormone and vitamin D metabolites. Am J Clin Nutr 67: 342-348, 1998 (Pubitemid 28076729)
29. Zhu K, Bruce D, Austin N, Devine A, Ebeling PR, Prince RL: Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res 23: 1343-1348, 2008 (Pubitemid 352040190)
30. Francis RM, Boyle IT, Moniz C, Sutcliffe AM, Davis BS, Beastall GH, Cowan RA, Downes N: A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures. Osteoporos Int 6: 284-290, 1996 (Pubitemid 26280821)
31. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B: Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes. Am J Clin Nut 84: 18-28, 2006 (Pubitemid 44699167)
32. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B: Positive association between 25-hydroxy vitamin d levels and bone mineral density: A population-based study of younger and older adults. Am J Med 116: 634-639, 2004 (Pubitemid 38490539)
33. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B: Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293: 2257-2264, 2005 (Pubitemid 40629192)
34. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, the Wom- en's Health Initiative Investigators: Calcium plus vitamin D: Supplementation and the risk of fractures. N Engl J Med 354: 669-683, 2006 (Pubitemid 43247138)
35. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327: 1637-1642, 1992
36. Holick MF: The D-lemma: To screen or not to screen for 25-hydroxyvitamin D concentrations. Clin Chem 56: 729-731, 2010
37. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-210, 2003 (Pubitemid 36015393)
38. Smith SM, Gardner KK, Locke J, Zwart SR: Vitamin D supplementation during Antarctic winter. Am J Clin Nutr 89: 1092-1098, 2009
39. Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, Muldowney S, Fitzgerald AP, Flynn A, Barnes MS, Horigan G, Bonham MP, Duffy EM, Strain JJ, Wallace JM, Kiely M: Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88: 1535-1542, 2008
40. Cashman KD, Wallace JM, Horigan G, Hill TR, Barnes MS, Lucey AJ, Bonham MP, Taylor N, Duffy EM, Seamans K, Muldowney S, Fitzgerald AP, Flynn A, Strain JJ, Kiely M: Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age. Am J Clin Nutr 89: 1366-1374, 2009
41. Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ: Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50: 59-68, 2007 (Pubitemid 46962851)
42. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr., Mehrotra R, Navaneethan SD: Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6: 50-62, 2011
43. Vieth R: Vitamin D toxicity, policy, and science. J Bone Min Res 22: V64-V68, 2007
44. Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168: 1629-1637, 2008
45. Jia X, Aucott LS, McNeill G: Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 98: 593-599, 2007 (Pubitemid 47272875)
46. Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P: Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 84: 616-622, 2006 (Pubitemid 44713413)
47. 3 synthesis in leptin-deficient mice [Abstract]. J Bone Min Res 25: 1711-1723, 2010
48. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch- Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le ML, Kolonel LN: Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 81-93, 2010
49. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108: 104-108, 2004 (Pubitemid 37444451)
50. Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA: Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 16: 2784-2786, 2007 (Pubitemid 351196338)
51. Miller AJ, Tsao H: New insights into pigmentary pathways and skin cancer. Br J Dermatol 162: 22-28, 2010
52. Barysch MJ, Hofbauer GF, Dummer R: Vitamin D, ultraviolet exposure, and skin cancer in the elderly. Gerontology 56: 410-413, 2010
53. Narayanan DL, Saladi RN, Fox JL: Ultraviolet radiation and skin cancer. Int J Dermatol 49: 978-986, 2010